Back
Novavax Inc (NVAX)
BiotechnologyNVAX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$12.75
+15.80%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$2.54
ROE
Gross margin
27.5%
Debt/Equity
Revenue growth
-79.1%
P/B ratio
Beta
Forward P/E
Novavax Inc — company intelligence
Earnings surprises
Q2 2026$-0.32 vs $-0.39 est+18.6%
Q1 2026$-0.06 vs $-0.23 est+74.5%
Q4 2025$0.11 vs $-0.50 est+122.1%
Q3 2025$-1.25 vs $-1.21 est-3.3%
Analyst consensus · 15 analysts
10 Buy2 Hold3 Sell
Updated Oct 9, 2026
Recent SEC filings
8-K — Material event reportAug 6, 2026
10-Q — Quarterly reportAug 6, 2026
4 — Insider transaction reportJun 23, 2026
Latest news
Sector Update: Healthcare Stocks Gain Late Afternoon — Yahoo · 1d ago
Sector Update: Healthcare Stocks Gain Friday Afternoon — Yahoo · 1d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.